The Latest
-
DraftKings Drops 7% In Pre-Market Amid Public Share Offering
-
Amarin, Apotex Settle Vascepa Dispute; Analyst Stays Sidelined
-
Chembio Sinks 59% In Pre-Market As FDA Revokes Its Covid-19 Test; Top Analyst Cuts Rating
-
EU calls for global alliance to buy COVID-19 vaccines up front